-
H 89 2HCl and Trigeminal Pain Signaling
2026-08-27
H 89 2HCl provides a pharmacological way to test whether cAMP/PKA signaling contributes to neuroinflammatory sensitization and mechanical allodynia. This article translates recent trigeminal nerve research into assay decisions, controls, and interpretation strategies.
-
PINK1, Mitophagy, and Bleomycin Lung Fibrosis
2026-08-26
A 2025 Cellular Signalling study identifies PINK1 as more than a driver of canonical PINK1/Parkin mitophagy: in bleomycin-induced pulmonary fibrosis, it suppresses BNIP3- and FUNDC1-mediated mitochondrial clearance. Using knockout mice and complementary epithelial and reporter-cell systems, the authors connect PINK1 deficiency with improved mitochondrial quality control, reduced epithelial apoptosis, and attenuated fibrosis.
-
Dextromethorphan Hydrobromide: NMDA Neuroprotection
2026-08-26
Dextromethorphan hydrobromide is an NMDA receptor antagonist used as a research tool for glutamate excitotoxicity, ion-channel modulation, and neuroprotection research. Product data report inhibition of NMDA-induced and voltage-operated inward currents, while the available evidence supports experimental interpretation rather than clinical efficacy claims.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-25
Pair direct Cy5 tracking with Firefly luciferase expression to separate delivery, intracellular localization, and productive translation in one assay. This dual-reporter design supports faster mRNA delivery and transfection optimization, from cell-based screening to in vivo bioluminescence imaging.
-
PX-478 in Prenatal Hypoxia–Related ASD
2026-08-25
A 2024 rat study found that postnatal PX-478 treatment reduced autism-like behaviors and hippocampal neuronal necrosis after prenatal hypoxia, while altering HIF-1α, PTEN, and VEGF-related readouts. The work positions HIF-1α inhibition as a mechanistic probe in prenatal hypoxia models, but its timing-dependent safety findings and lack of direct causal assays limit immediate translation.
-
DNase I (RNase-free) for RNA Workflows
2026-08-24
Improve RNA extraction, RT-PCR, and in vitro transcription sample preparation by removing DNA without introducing RNase activity. This guide also shows how cation selection and cleanup design can support chromatin and RNA vaccine workflows.
-
Penicillin G Sodium in Reliable Cell Assays
2026-08-23
Learn how Penicillin G Sodium (SKU B1678) can support contamination-aware cell viability, proliferation, and cytotoxicity workflows without confusing antimicrobial activity with mammalian-cell effects. This scenario-based guide covers assay compatibility, preparation, interpretation, and evidence-based product selection.
-
Maridomycin: In Vitro and In Vivo Activity
2026-08-22
Kondo and colleagues characterized maridomycin through a linked series of antimicrobial, resistance, pharmacological, and mouse infection experiments. The study established strong activity against many Gram-positive organisms, identified important assay-dependent effects, documented cross-resistance with macrolides, and showed therapeutic efficacy comparable to leucomycin in selected murine infections.
-
4-MUG: A Decision Tool for Gaucher Translation
2026-08-21
4-Methylumbelliferyl-β-D-Glucopyranoside converts glucosidase activity into a sensitive fluorescent endpoint, creating a practical bridge between GCase biology, mRNA engineering, and Gaucher disease translation. This article explains how to use 4-MUG strategically rather than treating it as merely another fluorogenic substrate.
-
SP600125: From JNK Mechanism to Translational Strategy
2026-08-21
SP600125 offers a practical way to interrogate JNK–c-Jun signaling while building a translational bridge between inflammation, apoptosis, cancer research, and radiation-induced neural differentiation. This article turns biochemical potency into an evidence-led experimental strategy, while separating established findings from testable hypotheses.
-
6-FAM SE: Durable Labeling Workflows
2026-08-20
6-FAM SE provides an amine-reactive route to durable fluorescent conjugates for oligonucleotides, proteins, peptides, and assay development. This guide connects practical labeling chemistry with nanoparticle tracking concepts inspired by a melanoma photothermal-immunotherapy study, while clearly separating established product properties from workflow recommendations.
-
0.4% Trypan Blue Solution: Practical Workflow
2026-08-20
0.4% Trypan Blue Solution provides a direct membrane-integrity readout for cell viability measurement and live/dead cell discrimination in cultured-cell workflows. It is suitable for research cell counting and cytotoxicity assays, but not for clinical diagnosis or for resolving apoptosis from necrosis.
-
Broad-Spectrum Bivalent mRNA Vaccine: Preclinical Evidence
2026-08-19
The reference study evaluates RQ3025, a bivalent mRNA vaccine designed around shared spike mutations from diverse SARS-CoV-2 evolutionary lineages. Across mouse, hamster, and rat models, the vaccine generated broad neutralizing responses, showed protection against several emerging variants, induced a Th1-biased cellular response, and produced no apparent organ pathology at a high tested dose.
-
Cyclic Pifithrin-α Hydrobromide: p53 Inhibitor
2026-08-19
Cyclic Pifithrin-α hydrobromide is a research-use p53 inhibitor that blocks p53-dependent gene transactivation. Its reported applications include apoptosis inhibition in cancer research, DNA-damage response studies, and protection from gamma irradiation in mice, but it is not a clinical radioprotective or anticancer treatment.
-
Concanamycin A: V-ATPase Workflow Guide
2026-08-18
Concanamycin A enables controlled disruption of lysosomal proton transport to separate acidification-dependent adaptation from terminal cancer-cell injury. This guide translates V-ATPase inhibition into practical workflows for metabolic-stress signaling, apoptosis, trafficking, and prostate cancer cell invasion inhibition, with troubleshooting guidance for reproducible assays.
457 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page